share_log

Leap Therapeutics Q1 Net Loss $10.4M vs Loss $9.1M In Same Qtr. Last Year, Sales $400.00K Up From $375.00K YoY

Benzinga Real-time News ·  May 13, 2022 19:23

Leap Therapeutics (NASDAQ:LPTX) reported $400.00 thousand in sales this quarter. This is a 6.67 percent increase over sales of $375.00 thousand the same period last year.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment